Skip to main content

Nonlinear Inverse Association Seen for Step Count, Peak Cadence With MACE

By Elana Gotkine HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

THURSDAY, Aug. 7, 2025 -- There are nonlinear, inverse associations for step count and peak cadence with the risk for major adverse cardiovascular events (MACE) among individuals with hypertension, according to a study published online Aug. 6 in the European Journal of Preventive Cardiology.

Sonia W.M. Cheng, Ph.D., from the University of Sydney, and colleagues obtained data for participants with established hypertension from the U.K. Biobank accelerometry substudy. Participants wore an accelerometer for seven consecutive days. Dose-response associations were examined for daily step count and peak 30-minute cadence with the risk for MACE among 36,192 participants.

The researchers observed nonlinear inverse dose-response associations for daily step count and peak 30-minute cadence with the risk for MACE during a follow-up of 7.8 years. The average risks for MACE, heart failure, myocardial infarction, and stroke were 17.1, 22.4, 9.3, and 24.5 percent lower, respectively, with each 1,000-step increase in daily step count. For people with and without hypertension, the magnitude of associations with increasing step count and stepping intensity was comparable for overall MACE, heart failure, and stroke, but lower for myocardial infarction.

"This study is one of the first to demonstrate a dose-response relationship between daily step count and major problems of the heart and blood vessels," supervising author Emmanuel Stamatakis, Ph.D., also from the University of Sydney, said in a statement. "In a nutshell, we found that, if you live with high blood pressure, the more you walk with greater intensity, the lower your risk for future serious cardiovascular events."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted August 2025

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.